This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Personalis, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Nicholas Phillips in Tumor Purity Estimation
Introduction
Nicholas Phillips is an accomplished inventor based in Menlo Park, CA. He has made significant contributions to the field of genomics, particularly in the estimation of tumor purity from single samples. His innovative approach has the potential to enhance cancer diagnostics and treatment strategies.
Latest Patents
Nicholas Phillips holds a patent for a method titled "Estimating tumor purity from single samples." This patent provides methods for estimating tumor purity from tumor samples without the need for matched-normal controls. The process involves identifying a set of genomic regions based on nucleic acid sequence data aligned to a reference genome. Each genomic region includes one or more nucleotide-sequence variants relative to the corresponding genomic region of the reference genome. A B-allele frequency distribution for the biological sample is determined based on the B-allele frequency for each genomic region. This distribution is then processed using a trained machine-learning model to estimate a metric identifying tumor purity in the biological sample. Nicholas holds 1 patent in this area.
Career Highlights
Nicholas Phillips is currently employed at Personalis, Inc., where he continues to work on innovative solutions in genomics. His expertise and dedication to advancing cancer research have made him a valuable asset to the company.
Collaborations
Nicholas collaborates with Jason Harris, leveraging their combined expertise to drive forward the research and development of genomic technologies.
Conclusion
Nicholas Phillips is a notable inventor whose work in estimating tumor purity has the potential to significantly impact cancer diagnostics. His contributions to the field exemplify the importance of innovation in healthcare.